Yang Chen

Dr. Yang Chen


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
WTWenmin Tian
Wenmin Tian
NZNan Zhang
Nan Zhang
RJRonghua Jin
Ronghua Jin
YFYingmei Feng
Yingmei Feng
SWSiyuan Wang
Siyuan Wang
CWCatherine C. L. Wong
Catherine C. L. Wong
The outbreak of COVID-19 has become a worldwide pandemic. The pathogenesis of this infectious disease and how it differs from other drivers of pneumonia is unclear. Here we analyze urine samples from COVID-19 infection cases, healthy donors and non-COVID-19 pneumonia cases using quantitative proteomics. The molecular changes suggest that immunosuppression and tight junction impairment occur in the early stage of COVID-19 infection. Further subgrouping of COVID-19 patients into moderate and severe types shows that an activated immune response emerges in severely affected patients. We propose a two-stage mechanism of pathogenesis for this unusual viral infection. Our data advance our understanding of the clinical features of COVID-19 infections and provide a resource for future mechanistic and therapeutics studies.

21 May 2019 in Cell Discovery
Verified
Journal Article
Open access
PDF file
XZXiaoxin Zhao
Xiaoxin Zhao
YLYaxin Lei
Yaxin Lei
JZJiajia Zheng
Jiajia Zheng
JPJunya Peng
Junya Peng
YLYing Li
Ying Li
YCYang Chen
Yang Chen

2 August 2021 in Cell Research
Verified
Journal Article
Open access
PDF file
WTWenmin Tian
Wenmin Tian
DLDelin Li
Delin Li
NZNan Zhang
Nan Zhang
GBGuijie Bai
Guijie Bai
KYKai Yuan
Kai Yuan
GGGeorge F. Fu Gao
George F. Fu Gao

24 March 2022 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
CZChuchu Zhou
Chuchu Zhou
ZWZhe Wu
Zhe Wu
WDWanqing Du
Wanqing Du
HQHuilin Que
Huilin Que
YWYufen Wang
Yufen Wang
YRYueguang Rong
Yueguang Rong

4 August 2020 in Cell Discovery
Verified
Journal Article
Open access
PDF file
PLPuzhong Lu
Puzhong Lu
RLRui Liu
Rui Liu
DLDi Lu
Di Lu
YXYue Xu
Yue Xu
XYXueyi Yang
Xueyi Yang
YCYang Chen
Yang Chen

15 January 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
WTWenmin Tian
Wenmin Tian
DSDongxue Shi
Dongxue Shi
YZYinmei Zhang
Yinmei Zhang
HWHongli Wang
Hongli Wang
HTHaohao Tang
Haohao Tang
YCYang Chen
Yang Chen
Proteins in the plasma/serum mirror an individual’s physiology. Circulating extracellular vesicles (EVs) proteins constitute a large portion of the plasma/serum proteome. Thus, deep and unbiased proteomic analysis of circulating plasma/serum extracellular vesicles holds promise for discovering disease biomarkers as well as revealing disease mechanisms. We established a workflow for simple, deep, and reproducible proteome analysis of both serum large and small EVs enriched fractions by ultracentrifugation plus 4D-data-independent acquisition mass spectrometry (4D-DIA-MS). In our cohort study of obstetric antiphospholipid syndrome (OAPS), 4270 and 3328 proteins were identified from large and small EVs enriched fractions respectively. Both of them revealed known or new pathways related to OAPS. Increased levels of von Willebrand factor (VWF) and insulin receptor (INSR) were identified as candidate biomarkers, which shed light on hypercoagulability and abnormal insulin signaling in disease progression. Our workflow will significantly promote our understanding of plasma/serum-based disease mechanisms and generate new biomarkers.